Results 151 to 160 of about 40,797 (259)

Risk Factors for Deep Venous Thrombosis Following Orthopaedic Trauma Surgery: An Analysis of 56,000 patients [PDF]

, 2016
Background: Deep venous thrombosis (DVT) and pulmonary embolism (PE) are recognized as major causes of morbidity and mortality in orthopaedic trauma patients.
Avilucea, F. R., Greenberg, S. E., Obremskey, W. T., Sethi, M. K., VanHouten, J. P., White-Dzuro, G. A., Whiting, P. S.   +6 more
core   +1 more source

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

The Lancet, 2021
E. Ramacciotti, Leandro Barile Agati, D. Calderaro, V. C. R. Aguiar, A. Spyropoulos, C. C. D. de Oliveira, Jessica Lins dos Santos, G. Volpiani, M. L. Sobreira, E. Joviliano, Milton Sérgio Bohatch Júnior, B. D. da Fonseca, M. Ribeiro, C. Dusilek, Kengi Itinose, Suzanna Maria Viana Sanches, Karine de Almeida Araujo Ramos, N. F. de Moraes, P. Tierno, André Luiz Malavasi Longo de Oliveira, A. Tachibana, R. Chate, M. V. B. Santos, Bruno Bezerra de Menezes Cavalcante, R. C. Moreira, C. Chang, A. Tafur, J. Fareed, R. Lopes, Tania Breno Marcello Igor Ivan Liane Lucas Carlos Ana Re Benevenuto Caltabiano Hattori da Silva Jardim Mari, Tania Benevenuto Caltabiano, B. Hattori, Marcello da Silva Jardim, Igor Marinho, Ivan Silva Marinho, Liane Mara Melo Batista, Lucas Rivabem, Carlos Alberto Kenji Nakashima, Ana Carla Gois Franco, Renata Fernanda de Oliveira Pereira, Giana Caroline Strack Neves, Izara de Castro e Souza, Bruno Moraes Ribas, Flavia Ramos Tristão, Marcus Vinicius Barbosa Santos   +44 more
semanticscholar   +1 more source

Global Thrombosis Test - a possible monitoring system for the effects and safety of dabigatran [PDF]

, 2015
© Otsui et al. 2015BACKGROUND: Dabigatran is an alternative to warfarin (WF) for the thromboprophylaxis of stroke in patients with non-valvular atrial fibrillation (NVAF). The advantage of dabigatran over WF is that monitoring is not required; however, a
Gorog, Diana A, Inoue, Nobutaka, Iwata, Sachiyo, Otsui, Kazunori, Ozawa, Toru, Suzuki, Atsushi, Takei, Asumi, Yamamoto, Junichiro, Yoshioka, Takayuki   +8 more
core   +2 more sources

The effect of new oral anticoagulants and extended thromboprophylaxis policy on hip and knee arthroplasty outcomes: observational study

Arthroplasty Today, 2015
The efficacy and safety of the new oral anticoagulants (NOAC) and the benefits of extended duration thromboprophylaxis following hip and knee replacements remain uncertain.
Alex Bottle, Emeka Oragui, Elizabeth Pinder, Paul Aylin, Mark Loeffler   +4 more
doaj   +1 more source

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients [PDF]

, 2011
The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term ...
, Goldhaber, Samuel Z, Haas, Sylvia K, Kakkar, Ajay K, Knabb, Robert M, Leizorovicz, Alain, Merli, Geno, Pedersen, Court, Weitz, Jeffrey I   +8 more
core   +3 more sources

Evaluation of an intervention for the use of thromboprophylaxis based on electronic alert transmission to first-year medical residents from two hospitals of Lima, Peru

Revista Peruana de Medicina Experimental y Salud Pública, 2016
Objectives. To assess the implementation of an intervention based on the sending of text messages and e-mails to internal medicine residents in order to achieve an increase in the prescription of thromboprophylaxis according to Clinical Practice ...
Roberto Delgado-Zapata, Ray Ticse, María de los Ángeles Gamarra, Katherine Gómez, Wilfredo Mormontoy   +4 more
doaj   +1 more source

The Impact of Deep Vein Thrombosis in Critically Ill Patients: A Meta-Analysis of major clinical outcomes [PDF]

, 2015
Background. Critically ill patients appear to be at high risk of developing deep vein thrombosis (DVT) and pulmonary embolism during their stay in the intensive care unit (ICU). However, little is known about the clinical course of venous thromboembolism
Boddi, M., Crowther, M., Dentali, F., Fabbiano, F., Gensini, G., Kagoma, Y., Malato, A., NAPOLITANO, Mariasanta, Peris, A., SIRAGUSA, Sergio   +9 more
core   +1 more source

The impact of pharmacological thromboprophylaxis and disease-stage on postoperative bleeding following colorectal cancer surgery

World Journal of Surgical Oncology, 2019
Background Pharmacological thromboprophylaxis after colorectal cancer (CRC) surgery is internationally recommended for venous thromboembolism (VTE) prevention. The aim of this retrospective study was to evaluate the risk factors of postoperative bleeding
Hiroyuki Ohta, Toru Miyake, Tomoharu Shimizu, Hiromichi Sonoda, Tomoyuki Ueki, Sachiko Kaida, Tsuyoshi Yamaguchi, Hiroya Iida, Masaji Tani   +8 more
doaj   +1 more source

Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER) [PDF]

, 2017
Background: Venous thromboembolism (VTE) prophylaxis remains underutilized, particularly in cancer patients. We explored clinical predictors of prophylaxis in hospitalized cancer patients before the onset of acute VTE.
Banyai, M., Baumgartner, I., Bounameaux, H., Korte, W., Kucher, N., Mazzolai, L., Nobel, D., Spirk, D.   +7 more
core  

Anticoagulant therapy in orthopedic surgery – a review on anticoagulant agents, risk factors, monitoring, and current challenges

Journal of Orthopaedic Surgery
Orthopedic surgeries are associated with high-risk of thromboembolism which occurs in 40% to 60% of orthopedic patients in the absence of thromboprophylaxis. Conventionally heparin anticoagulants were used for thromboprophylaxis and currently direct oral
Yiqun Wang, Xiaobin Xu, Wei Zhu
doaj   +1 more source